Alzheimer's. Study presents new way to detect risk
It is through blood biomarkers that such is possible. The recent investigation was published in the journal Brain.
© Shutterstock
Lifestyle Alzheimer
Another step has been taken against Alzheimer's disease. A new study published in the journal Brain, and carried out by the Center for Research in Neurological Diseases, reveals that with a blood test it is possible to detect blood biomarkers that are important for identifying the pathology.
"There is a link between blood levels of glial fibrillary acidic protein [GFAP, acronym in English] and the development of the disease," reveal the authors of the study, quoted here by the newspaper El Mundo.
Also Read: To strengthen the brain, bet on these four exercises (Portuguese version)
In this way, a direct relationship is made between this protein and the activation of brain cells, which are crucial for the inflammatory processes of this disease. According to the study, this discovery may pave the way for a more accurate diagnosis and also for possible treatments.
They explain that astrocytes, brain cells typical of Alzheimer's characteristic lesions, are considered the third element of the disease and play an important role in brain inflammation.
"High levels of GFAP are associated with greater disease progression, greater cognitive decline, and lower brain weight," they continue.
Also Read: Five tricks from a neuroscientist to strengthen memory (Portuguese version)
Descarregue a nossa App gratuita.
Oitavo ano consecutivo Escolha do Consumidor para Imprensa Online e eleito o produto do ano 2024.
* Estudo da e Netsonda, nov. e dez. 2023 produtodoano- pt.com